Morepen Laboratories has informed that the Board of Directors of the Company at its meeting held on May 15, 2015, have taken up pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Circular dated May 11, 2015 issued by Securities and Exchange Board of India in that regard, the Board at its meeting held on May 15, 2015 have approved and adopted the following Codes to be effective from May 15, 2015, ‘Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information’ pursuant to Regulation 8 of the Regulations (copy enclosed) and ‘Code of Conduct to Regulate, Monitor and Report Trading by Insiders’pursuant to Regulation 9 of the Regulations.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: